VCEL logo

Vericel (VCEL)

Profile

Full Name

Vericel Corporation

Ticker Symbol

VCEL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 4, 1997

Indexes

Not included

Website

http://www.vcel.com

Employees

357

Key Details

Price

$41.25(-1.55%)

Market cap

$2.06B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$237.22M(+20.10% YoY)

Annual EPS

$0.20(+385.71% YoY)

PE ratio

229.17

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$41.25
VCEL price is $41.25

30-Day Relative Volume

1.16
VCEL 30-day relative volume is 1.16

Price Performance

Price Today change

-1.55%
VCEL price is down -1.55% today

Price YTD change

-24.88%
VCEL price is down -24.88% since January 1st

Price 1-year change

-15.33%
VCEL price is down -15.33% year-on-year

Price 3-year change

+13.54%
VCEL price is up +13.54% over the past 3 years

Price Range

Price All-time high

$1590.00
VCEL price is currently -97.41% below its historical high of $1590.00

Price 3-year low

$17.30
VCEL price is currently +138.44% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.06B
VCEL market capitalization is $2.06 billion

Market cap 3-year change

+20.51%
VCEL market capitalization is up +20.51% over the past 3 years

Market cap All-time high

$3.14B
VCEL market capitalization is currently -34.43% below its historical high of $3.14 billion

Market cap sector rank

83.65%
VCEL market capitalization is higher than 83.65% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.05%
VCEL shares outstanding is up +3.05% year-on-year

Shares Outstanding 3-Year Change

+6.14%
VCEL shares outstanding is up +6.14% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.17
VCEL beta is 1.17

200-day SMA

$50.15
VCEL price is currently -17.75% below its 200-day simple moving average

50-day SMA

$49.95
VCEL price is currently -17.42% below its 50-day simple moving average

RSI

39.22
VCEL 14-day relative strength index is 39.22

Volume

1.16
VCEL 30-day relative volume is 1.16

ATR

$2.71
VCEL average true range is $2.71

10-day Historical Volatility

93.21%
VCEL 10-day historical volatility is 93.21%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$237.22M
VCEL annual revenue is $237.22 million

Revenue Analysts estimate

$286.63M
VCEL annual revenue is currently -17.24% lower than the consensus analysts' forecast

Revenue 1-year change

+20.1%
VCEL annual revenue is up +20.1% year-on-year

Revenue Sector rank

66.41%
VCEL annual revenue is higher than 66.41% of companies in Healthcare sector

EPS

EPS

$0.20
VCEL annual earnings per share is $0.20

EPS Analysts estimate

$0.30
VCEL annual earnings per share is currently -33.77% lower than the consensus analysts' forecast

EPS 1-year change

+385.71%
VCEL annual earnings per share is up +385.71% year-on-year

EPS Sector rank

84.97%
VCEL annual earnings per share is higher than 84.97% of companies in Healthcare sector

Profit

Gross profit

$172.11M
VCEL annual gross profit is $172.11 million

Gross margin

72.55%
VCEL annual gross profit margin is 72.55%

Operating profit

$4.52M
VCEL annual operating income is $4.52 million

Operating margin

1.91%
VCEL annual operating profit margin is 1.91%

Net income

$10.36M
VCEL annual net profit is $10.36 million

Net margin

4.37%
VCEL annual net profit margin is 4.37%

Expenses

Total expenses

$232.71M
VCEL annual total expenses is $232.71 million

Operating expenses

$167.59M
VCEL annual total operating expenses is $167.59 million

Cost of goods sold

$65.12M
VCEL annual cost of goods sold is $65.12 million

Selling, general & administrative expenses

$142.79M
VCEL annual SGA is $142.79 million

Depreciation and amortization

$5.50M
VCEL annual depreciation & amortization is $5.50 million

Interest expense

$614.00K
VCEL annual interest expense is $614.00 thousand

Income tax

$148.00K
VCEL annual income tax is $148.00 thousand

EBIT & EBITDA

EBIT

$11.12M
VCEL annual earnings before interest & taxes is $11.12 million

EBITDA

$16.63M
VCEL annual EBITDA is $16.63 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$432.72M
VCEL annual total assets is $432.72 million

Non current assets

$219.94M
VCEL annual long term assets is $219.94 million

Current assets

$212.78M
VCEL annual total current assets is $212.78 million

Cash and cash equivalents

$74.52M
VCEL annual cash & cash equivalents is $74.52 million

Accounts receivable

$61.38M
VCEL annual accounts receivable is $61.38 million

Inventory

$17.37M
VCEL annual inventory is $17.37 million

Liabilities

Total liabilities

$140.75M
VCEL annual total liabilities is $140.75 million

Long term liabilities

$90.47M
VCEL annual total long term liabilities is $90.47 million

Current liabilities

$50.29M
VCEL annual total current liabilities is $50.29 million

Accounts payable

$23.85M
VCEL annual accounts payable is $23.85 million

Debt

Total debt

$98.85M
VCEL annual total debt is $98.85 million

Total debt 1-year change

+12.27%
VCEL annual total debt is up +12.27% year-on-year

Long term debt

$89.59M
VCEL annual long term debt is $89.59 million

Short term debt

$9.26M
VCEL annual short term debt is $9.26 million

Equity & Capital

Shareholders equity

$291.97M
VCEL annual stockholders equity is $291.97 million

Book value

$291.97M
VCEL annual book value is $291.97 million

Retained earnings

-$392.81M
VCEL annual retained earnings is -$392.81 million

Working capital

$162.49M
VCEL annual working capital is $162.49 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$58.16M
VCEL annual cash flow from operations is $58.16 million

Cash from operations 1-year change

+64.72%
VCEL annual cash flow from operations is up +64.72% year-on-year

Cash from investing

-$79.03M
VCEL annual cash flow from investing activities is -$79.03 million

Cash from investing 1-year change

-2425.05%
VCEL annual cash flow from investing activities is down -2425.05% year-on-year

Cash from financing

$19.05M
VCEL annual cash flow from financing activities is $19.05 million

Cash from financing 1-year change

+426.64%
VCEL annual cash flow from financing activities is up +426.64% year-on-year

CAPEX

CAPEX

$63.97M
VCEL annual capital expenditures is $63.97 million

CAPEX 1-year change

+132.52%
VCEL annual capital expenditures is up +132.52% year-on-year

Free Cash Flow

Free cash flow

-$5.81M
VCEL annual free cash flow is -$5.81 million

Free cash flow 1-year change

-174.52%
VCEL annual free cash flow is down -174.52% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

72.55%
VCEL annual gross profit margin is 72.55%

Operating margin

1.91%
VCEL annual operating profit margin is 1.91%

Net margin

4.37%
VCEL annual net profit margin is 4.37%

ROA & ROE

ROA

2.64%
VCEL annual return on assets is 2.64%

ROE

4.00%
VCEL annual return on equity is 4.00%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

229.17
VCEL price to earnings ratio is 229.17

PE ratio Sector rank

96.06%
VCEL price to earnings ratio is higher than 96.06% of companies in Healthcare sector

PB Ratio

PB ratio

7.06
VCEL price to book ratio is 7.06

PB ratio Sector rank

88.9%
VCEL price to book ratio is higher than 88.9% of companies in Healthcare sector

PS Ratio

PS ratio

8.69
VCEL price to sales ratio is 8.69

PS ratio Sector rank

77.31%
VCEL price to sales ratio is higher than 77.31% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.09B
VCEL enterprise value is $2.09 billion

Enterprise value Sector rank

82.52%
VCEL enterprise value is higher than 82.52% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

125.43
VCEL EV/EBITDA is 125.43

EV/EBITDA Sector rank

98.96%
VCEL EV/EBITDA is higher than 98.96% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.23
VCEL annual current ratio is 4.23

Quick ratio

3.89
VCEL annual quick ratio is 3.89

Leverage

Debt to equity

0.00
VCEL annual debt to equity ratio is 0.00

Interest coverage ratio

18.12
VCEL annual interest coverage ratio is 18.12

Risk & Stability

Piotroski F-Score

5
VCEL piotroski f-score is 5

Altman Z-Score

8.60
VCEL altman z-score is 8.60

Analyst ratings

Recent major analysts updates

Mar 3, 25 Truist Securities
Buy
Feb 28, 25 HC Wainwright & Co.
Buy
Feb 3, 25 Canaccord Genuity
Buy
Jan 15, 25 Stephens & Co.
Overweight
Jan 15, 25 HC Wainwright & Co.
Buy
Dec 18, 24 Truist Securities
Buy
Nov 26, 24 BTIG
Buy
Nov 19, 24 Canaccord Genuity
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Aug 27, 24 TD Cowen
Buy

Institutional Ownership

Similar stocks

IBRX logo
ImmunityBio (IBRX)
SEM logo
Select Medical Holdings (SEM)
HCM logo
HUTCHMED (China) Limited (HCM)
MLTX logo
MoonLake Immunotherapeutics (MLTX)
AMRX logo
Amneal Pharmaceuticals (AMRX)
TWST logo
Twist Bioscience (TWST)
FOLD logo
Amicus Therapeutics (FOLD)
LGND logo
Ligand Pharmaceuticals Incorporated (LGND)
AGL logo
agilon health (AGL)
  • What is the ticker symbol for Vericel?
  • Does Vericel pay dividends?
  • What sector is Vericel in?
  • What industry is Vericel in?
  • What country is Vericel based in?
  • When did Vericel go public?
  • Is Vericel in the S&P 500?
  • Is Vericel in the NASDAQ 100?
  • Is Vericel in the Dow Jones?
  • When was Vericel's last earnings report?
  • When does Vericel report earnings?
  • Should I buy Vericel stock now?

What is the ticker symbol for Vericel?

The ticker symbol for Vericel is NASDAQ:VCEL

Does Vericel pay dividends?

No, Vericel does not pay dividends

What sector is Vericel in?

Vericel is in the Healthcare sector

What industry is Vericel in?

Vericel is in the Biotechnology industry

What country is Vericel based in?

Vericel is headquartered in United States

When did Vericel go public?

Vericel's initial public offering (IPO) was on February 4, 1997

Is Vericel in the S&P 500?

No, Vericel is not included in the S&P 500 index

Is Vericel in the NASDAQ 100?

No, Vericel is not included in the NASDAQ 100 index

Is Vericel in the Dow Jones?

No, Vericel is not included in the Dow Jones index

When was Vericel's last earnings report?

Vericel's most recent earnings report was on Feb 27, 2025

When does Vericel report earnings?

The next expected earnings date for Vericel is May 8, 2025

Should I buy Vericel stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page